Search Result "CYP3A-humanized mice."
Gender Difference of Hepatic and Intestinal CYP3A4 in CYP3AHumanized Mice Generated by a Human Chromosome-engineering Technique
Journal: Drug Metabolism Letters
Volume: 11 Issue: 1 Year: 2017 Page: 60-67
Author(s): Kaoru Kobayashi,Chihiro Abe,Mika Endo,Yasuhiro Kazuki,Mitsuo Oshimura,Kan Chiba
CYP2C and CYP2B Mediated Metabolic Activation of Retrorsine in Cyp3a Knockout Mice
Journal: Current Drug Metabolism
Volume: 21 Issue: 13 Year: 2020 Page: 1040-1051
Author(s): Xiaoyan Pang,Chongzhuang Tang,Fandi Kong,Meixia Chen,Xiaoyan Chen
Quantitative Relationship Between Rifampicin Exposure and Induction of CYP3a11 in SXR Humanized Mice: Extrapolation to Human CYP3A4 Induction Potential
Journal: Drug Metabolism Letters
Volume: 2 Issue: 3 Year: 2008 Page: 169-175
Author(s): Sean Kim, Devin Pray, Ming Zheng, Danial G. Morgan, Jenifer G. Pizzano, Mary E. Zoeckler, Anjaneya Chimalakonda, Michael W. Sinz
Pharmacokinetic Interaction Between Verapamil and Methylxanthine Derivatives in Mice
Journal: Drug Metabolism Letters
Volume: 4 Issue: 1 Year: 2010 Page: 15-24
Author(s): Elzbieta Wyska
Effect of Piperine on Liver Function of CF-1 albino Mice
Journal: Infectious Disorders - Drug Targets
Volume: 15 Issue: 2 Year: 2015 Page: 131-134
Author(s): Peela J. Rao,Shoba D. Kolla,Farag Elshaari,Fatoom Elshaari,Hayam El Awamy,Mona Elfrady,Rajinder Singh,Asma Belkhier,Shakila Srikumar,Abdul R. Said,Sainath J. Dhopoide,Ranjani Ramanujam,Idris Elbarassi,Laxmi T. Peela,Anuradha Argi
Variability of Zaleplon 5-Oxidase Activity in Mice and Humans, and Inhibition by Raloxifene
Journal: Drug Metabolism Letters
Volume: 10 Issue: 4 Year: 2016 Page: 278-285
Author(s): Chiaki Tanoue,Kazumi Sugihara,Yoshitaka Tayama,Naoto Uramaru,Yoko Watanabe,Shigeru Ohta,Shigeyuki Kitamura
Quantitative Proteomics Reveals Changes in Transporter Protein Abundance in Liver, Kidney and Brain of Mice by Pregnancy
Journal: Drug Metabolism Letters
Volume: 12 Issue: 2 Year: 2018 Page: 145-152
Author(s): Michael Z. Liao,Chunying Gao,Deepak Kumar Bhatt,Bhagwat Prasad,Qingcheng Mao
Metabolism and Disposition of Pacritinib (SB1518), an Orally Active Janus Kinase 2 Inhibitor in Preclinical Species and Humans
Journal: Drug Metabolism Letters
Volume: 9 Issue: 1 Year: 2015 Page: 28-47
Author(s): Ramesh Jayaraman,Mohammed Khalid Pasha,Anthony Williams,Kee Cee Goh,Kantharaj Ethirajulu
Comparative Pharmacokinetics and Metabolism Studies in Lean and Diet- Induced Obese Mice: An Animal Efficacy Model for 11β -Hydroxysteroid Dehydrogenase Type 1 (11β -HSD1) Inhibitors
Journal: Drug Metabolism Letters
Volume: 5 Issue: 1 Year: 2011 Page: 55-63
Author(s): Mengmeng Wang, Xianbin Tian, Louis Leung, Jianyao Wang, Nicole Houvig, Jason Xiang, Eddine Saiah, Seung Hahm, Vipin Suri, Xin Xu
Utility of Mdr1-Gene Deficient Mice in Assessing the Impact of P-glycoprotein on Pharmacokinetics and Pharmacodynamics in Drug Discovery and Development
Journal: Current Drug Metabolism
Volume: 4 Issue: 4 Year: 2003 Page: 272-291
Author(s): Cuiping Chen, Xingrong Liu, Bill J. Smith